Assiz & Sarah Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.68 M
as on 24-10-2024
- Revenue 23.90%
(FY 2023)
- Profit 212.11%
(FY 2023)
- Ebitda 288.20%
(FY 2023)
- Net Worth 31.33%
(FY 2023)
- Total Assets 19.28%
(FY 2023)
About Assiz & Sarah Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.68 M.
Mundakathil Nizar and Ravinder Saini serve as directors at the Company.
- CIN/LLPIN
U24233DL2013PTC247726
- Company No.
247726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Assiz & Sarah Healthcare Private Limited offer?
Assiz & Sarah Healthcare Private Limited offers a wide range of products and services, including Orthopedic Equipment & Supplies, Orthopedic Implants, Surgical & ICU Equipments, CPAP, BiPAP Machine & Accessories, Oxygen Mask, Scalpels, Needles & Scissors, Surgical Staplers.
Who are the key members and board of directors at Assiz & Sarah Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mundakathil Nizar  | Director | 28-Jun-2016 | Current |
| Ravinder Saini | Director | 26-Apr-2024 | Current |
Financial Performance of Assiz & Sarah Healthcare.
Assiz & Sarah Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.9% increase. The company also saw a substantial improvement in profitability, with a 212.11% increase in profit. The company's net worth Soared by an impressive increase of 31.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assiz & Sarah Healthcare?
In 2023, Assiz & Sarah Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jul 2024 | ₹4.68 M | Open |
How Many Employees Work at Assiz & Sarah Healthcare?
Unlock and access historical data on people associated with Assiz & Sarah Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assiz & Sarah Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assiz & Sarah Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
